# Opus Genetics, Inc.: Form 10-Q for the period ended Jun 30, 2018

- Company: [Opus Genetics, Inc.](/companies/ird.md) (CIK 1228627)
- Form: 10-Q
- Filed: 2018-08-03
- Accepted by EDGAR: Aug 3, 2018, 16:21 ET
- Period: 2018-06-30
- Accession: 0001140361-18-035394
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1228627/000114036118035394/form10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1228627/000114036118035394/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2018-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Research and development | 3 months, 2018-04-01 to 2018-06-30 | $3.4m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months, 2018-01-01 to 2018-06-30 | $7.5m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months, 2018-04-01 to 2018-06-30 | −$5.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2018-01-01 to 2018-06-30 | −$10.9m | us-gaap:OperatingIncomeLoss |
| Net income | 3 months, 2018-04-01 to 2018-06-30 | −$3.8m | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2018-01-01 to 2018-06-30 | −$5.9m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2018-04-01 to 2018-06-30 | −$0.12 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months, 2018-01-01 to 2018-06-30 | −$0.19 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2018-04-01 to 2018-06-30 | −$0.12 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months, 2018-01-01 to 2018-06-30 | −$0.19 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2018-04-01 to 2018-06-30 | 31,744,439 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months, 2018-01-01 to 2018-06-30 | 31,737,998 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months, 2018-01-01 to 2018-06-30 | −$10.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | at 2018-06-30 | $5.1m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2018-06-30 | $18.1m | us-gaap:AssetsCurrent |
| Total assets | at 2018-06-30 | $18.2m | us-gaap:Assets |
| Total liabilities | at 2018-06-30 | $6.8m | us-gaap:Liabilities |
| Shareholders' equity | at 2018-06-30 | $11.4m | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1228627/000114036118035394/form10q.htm

Filed Aug 3, 2018.
Source: SEC EDGAR, the filing index for accession 0001140361-18-035394. Last ingested by Listed: Nov 12, 2026, 19:22 ET. No prices; not investment advice.
